WSD-0628

N/A

Report date: 2023/02/09 09:32:19
NME

Base Information

Drug NameWSD-0628
Drug Alias NameWSD-0628
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine-protein kinase ATM inhibitors
TargetsSerine-protein kinase ATM
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesWayshine Biopharm International Ltd
China Registration ClassN/A

Develop Information

Active CompaniesWayshine Biopharm International Ltd
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A